EyePoint, Inc. Deferred Income Tax Expense (Benefit)
EyePoint, Inc. (EYPT) reported Deferred Income Tax Expense (Benefit) of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-05
- EyePoint, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $369.00K, a 310.00% increase year-over-year.
- EyePoint, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- EyePoint, Inc. deferred income tax expense (benefit) for the quarter ending 2024-12-31 was $90.00K.
- EyePoint, Inc. deferred income tax expense (benefit) for the quarter ending 2024-09-30 was $0.00.
- EyePoint, Inc. deferred income tax expense (benefit) for fiscal 2025 was $279.00K, a 210.00% increase from fiscal 2024.
- EyePoint, Inc. deferred income tax expense (benefit) for fiscal 2024 was $90.00K, a 8.43% increase from fiscal 2023.
- EyePoint, Inc. deferred income tax expense (benefit) for fiscal 2023 was $83.00K.
- EyePoint, Inc. deferred income tax expense (benefit) for fiscal 2012 was -$13.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $369.00K derived: sum of 2 quarters · filed 2026-03-05 | $279.00K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$90.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$90.00K 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $90.00K derived: sum of 2 quarters · filed 2026-03-05 | $90.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $83.00K 10-K · filed 2025-03-06 | |||
| 2012-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | $0.00 derived: sum of 2 quarters · filed 2013-09-27 | $0.00 derived: sum of 3 quarters · filed 2013-09-27 | -$13.00K 10-K · filed 2013-09-27 |
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-14 | $0.00 derived: sum of 2 quarters · filed 2013-05-14 | -$13.00K 10-Q · filed 2013-05-14 | -$132.00K derived: sum of 4 quarters · filed 2013-09-27 |
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-08 | -$13.00K 10-Q · filed 2013-02-08 | -$132.00K derived: sum of 3 quarters · filed 2013-09-27 | |
| 2011-09-30 | -$13.00K 10-Q · filed 2012-11-09 | -$132.00K derived: sum of 2 quarters · filed 2013-09-27 | ||
| 2011-06-30 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | -$209.00K 10-K · filed 2013-09-27 | ||
| 2011-03-31 | -$90.00K 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |